GeneDx Board Member Joshua Ruch Expands Stake with Latest Stock Award
Rhea-AI Filing Summary
GeneDx Holdings Corp. (WGS) director Joshua Ruch reported multiple transactions in a Form 4 filing dated June 28, 2025. Key transactions include:
- Acquisition of 12,924 shares of Class A Common Stock through the conversion of Restricted Stock Units (RSUs) on June 18, 2025, at $0 cost
- Receipt of 3,576 new RSUs on June 18, 2025, which vest at the earlier of next annual shareholder meeting or first grant anniversary
Following these transactions, Ruch's beneficial ownership consists of:
- 29,723 shares held directly
- 194,267 shares held indirectly through various entities: - 14,845 via Kariba LLC - 30,138 via Rugu2 LLC - 149,284 via VAAL Investment Partners Q9 LP
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 12,924 shares
Net Buy
6 txns
Insider
RUCH JOSHUA
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 3,576 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit | 12,924 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 12,924 | $0.00 | $0.00 |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 3,576 shares (Direct);
Class A Common Stock — 29,723 shares (Direct);
Class A Common Stock — 14,845 shares (Indirect, See Kariba LLC);
Class A Common Stock — 30,138 shares (Indirect, See Rugu2 LLC);
Class A Common Stock — 149,284 shares (Indirect, See VAAL Investment Partners Q9 LP)
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- F2. The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
When will Joshua Ruch's new WGS RSUs vest?
The RSUs will vest at the earlier of: (a) the date of the next annual meeting of GeneDx Holdings' shareholders following the grant date, or (b) the first anniversary of the grant date, subject to Ruch continuing to provide services to the company through the vesting date.
What was the exercise price of WGS RSUs granted to Joshua Ruch?
The RSUs were granted with no exercise price. Each RSU represents a contingent right to receive 1 share of GeneDx Holdings' Class A Common Stock upon settlement for no consideration ($0).